CLINICAL_TRIALS
trial_result
· 2024-11-08
Clinical Trial Update: Impact of Symbiofilm On Nasal Microbiota
Summary
A completed clinical trial from Lallemand Pharma AG evaluated the impact of Symbiofilm on the nasal microbiota in chronic rhinosinusitis; results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lallemand Pharma AG | Conditions: Rhinosinusitis Chronic, Microbiome | Status: COMPLETED | Results posted: 2024-11-08